The Teracor project for the correction of visual disorders with theranostics is moving forward quickly

We are thrilled to announce an important milestone in our Teracor project! At the Intermediate Progress Report of the project funded with European funds by Lazio Innova, we have completed over 60% of the planned objectives! The Teracor project aims to revolutionize the treatment of ocular refractive errors, such as myopia and presbyopia, with an innovative theranostic platform, which allows vision correction without the need for ocular incisions. The Regensight Team plans to complete pre-clinical testing and industrial prototyping by summer 2025. A heartfelt thank you to the entire team for their hard work and continued commitment. We will continue to work with passion to achieve our goal of improving the quality of life of people around the world.